International health bodies have issued alerts regarding counterfeit 'Abhayrab' rabies vaccines in India, prompting calls for replacement doses for travelers. The manufacturer acknowledges a single counterfeit batch, while global advisories suggest wider circulation since November 2023, highlighting critical supply chain transparency issues.
Read the full story on Quick Digest